- Home
- About
- Find staff
- Axel Stenmark Tullberg
Axel Stenmark Tullberg
Affiliated to Research
Department ofAbout Axel Stenmark Tullberg
Axel Stenmark Tullberg will defend his doctoral thesis in the research subject of oncology, October 21, 2022
The title of his/her thesis is – The use of immunological biomarkers to improve individualization of postoperative radiotherapy in breast cancer
-
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT
Trial.
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander, S Laura Chang, Felix Y Feng, Corey W Speers, Lori J Pierce, Anikó Kovács, Dan Lundstedt, Erik Holmberg, Per Karlsson
Clinical cancer research : an official journal of the American Association for Cancer Research - 2023 -
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized
trial.
Moa Egelberg, Tommaso De Marchi, Gyula Pekar, Lena Tran, Pär-Ola Bendahl, Axel Stenmark Tullberg, Erik Holmberg, Per Karlsson, Marianne Farnebo, Fredrika Killander, Emma Nimeús
Molecular oncology - 2023 -
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical
trial.
Axel Stenmark Tullberg, Martin Sjöström, Lena Tran, Emma Niméus, Fredrika Killander, Anikó Kovács, Dan Lundstedt, Erik Holmberg, Per Karlsson
Journal for immunotherapy of cancer - 2023 -
Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast
cancer.
Amalia H Landén, Kian Chin, Anikó Kovács, Erik Holmberg, Eva Molnar, Axel Stenmark Tullberg, Fredrik Wärnberg, Per Karlsson
Acta oncologica (Stockholm, Sweden) - 2023 -
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy
trial.
Aglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, Helena Olofsson, Amanda Lindberg, Erik Holmberg, Troy Bremer, Patrick Micke, Per Karlsson, Fredrik Wärnberg, Carina Strell
European journal of cancer - 2022 -
The use of immunological biomarkers to improve individualization of postoperative radiotherapy in breast
cancer
-
Immune infiltrate in the primary tumor predicts effect of adjuvant radiotherapy in breast cancer; results from the randomized SweBCG91RT
trial.
Axel Stenmark Tullberg, Henri A J Puttonen, Martin Sjöström, Erik Holmberg, S Laura Chang, Felix Y Feng, Corey Speers, Lori J Pierce, Dan Lundstedt, Fredrika Killander, Emma Niméus, Anikó Kovács, Per Karlsson
Clinical cancer research : an official journal of the American Association for Cancer Research - 2021 -
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT
trial
Carina Strell, Axel Stenmark Tullberg, Reidunn Jetne Edelmann, Lars Andreas Akslen, Per Malmström, Mårten Fernö, Erik Holmberg, Arne Östman, Per Karlsson
Breast cancer research and treatment - 2021 -
Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized
Trial.
Anikó Kovács, Axel Stenmark Tullberg, Elisabeth Werner Rönnerman, Erik Holmberg, Linda Hartman, Martin Sjöström, Dan Lundstedt, Per Malmström, Mårten Fernö, Per Karlsson
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 2019 -
Positive sentinel node in luminal A-like breast cancer patients - implications for adjuvant
chemotherapy?
Axel Stenmark Tullberg, Dan Lundstedt, Roger Olofsson Bagge, Per Karlsson
Acta Oncologica - 2019